https://www.live-feeds.com/feed/living-drugs-transformed-blood-cancer-treatment-and-that-s-just-the-beginningContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/living-drugs-transformed-blood-cancer-treatment-and-that-s-just-the-beginninghttps://www.live-feeds.com/feed/living-drugs-transformed-blood-cancer-treatment-and-that-s-just-the-beginning#u89219Tue, 29 Sep 2026 15:26:59 +0000Living drugs such as CAR-T cell therapy have transformed blood cancer treatment, marking what the American Cancer Society described in January as a golden era of cancer care. Recent approvals in August have further expanded treatment options alongside bispecific therapies, reshaping how medical professionals approach hematological malignancies. Researchers are now actively working to push these cellular therapies beyond blood cancers to target solid tumors, autoimmune diseases, HIV, and fibrosis. Life-years saved metrics are increasingly used to capture both the major gains and remaining gaps